The vulnerability of the developing CNS to hypoxia-ischemia (H-I) differs from that of the mature brain and is due in part to release of nitric oxide (NO) from parenchymal neurons. If NO is important in the generation of excitotoxic injury after H-I in the developing CNS, then selective destruction of the neuronal nitric oxide synthase (nNOS) cells before H-I should lessen the injury seen after the insult. Using low dose quisqualic acid (QA) injected into neonatal (postnatal d 7) parietal cortex, the nNOS neurons were eliminated while sparing other neuronal and glial populations as ascertained by NADPH diaphorase histochemistry, nNOS immunocytochemistry, and Nissl counterstain. Animals subjected to focal ischemia followed by global hypoxia 24 h after the intracortical injection of QA had more viable cortex remaining than vehicle-injected animals (83.4 5 4.3% versus 62.7 i-8.3%) and lower injury severity represented by less neuronal loss and gliosis. Intracortical injections of QA without H-I resulted in minimal cell loss at the injection site with elimination of nNOS neurons throughout the parietal cortex.
ters such as glutamate participate in brain damage caused by hypoxia and ischemia, and the neuropathologic effects of ischemia can be attenuated by antagonists effective at a specific subclass of glutamate receptors, the NMDA receptor (2) .
Recent experiments suggest a role for NO in modulating glutamate neurotoxicity. It has been shown that, in primary cerebral cortical cell culture, glutamate neurotoxicity can be prevented by L-nitroarginine, an inhibitor of NO production (3) . In coronal slices of mature rat brain incubated with NMDA, preincubation with L-nitroarginine attenuates the toxicity of NMDA (4) . Therefore, the neurotoxicity associated with cerebral ischemia appears to involve glutamatergic stimulation of NO production via NMDA receptors. A subpopulation of neurons has been shown to contain a constitutive NOS, called nNOS, and in the setting of H-I, nNOS is activated by increased intracellular calcium (5) . The increased NOS activity results in large amounts of NO diffusing out of the nNOS neuron to form reactive oxygen intermediates that kill nearby cells (6) . Recently , it has been shown that, in adult mice deficient in nNOS, infarct size is reduced after middle cerebral artery occlusion (7) . nNOS mRNA and immunoreactivity has been localized in the rat brain to a distinct, small subpopulation of neurons previously identified as NADPHd-containing neurons (8) . Interestingly, these NADPHd-positive, nNOS-immunoreactive neurons are relatively resistant to NMDA-mediated cell death. In murine cortical cell cultures derived from embryonic rat brain, exposure to quinolinate (an NMDA agonist) kills most neurons, but NADPHd-reactive neurons are spared (9) . In a model of H-I in infant rats, these neurons are selectively PERINATAL HYPOXIA-ISCHEMIA AND NITRIC OXIDE 913 preserved after ischemic cell death and NMDA agonist injection (10) . After the postnatal period, the selective resistance of these cells to ischemia progressively diminishes (1 1).
Despite their selective resistance to NMDA, the NADPHdI NOS neurons are more susceptible than other neurons to kainate or QA toxicity (1 1, 12) . Low concentrations of QA kill NADPHd-containing neurons without producing general neuronal injury in murine cortical neuronal culture. High doses of any glutamate agonist, on the other hand, will produce nonselective neuronal injury. The differential susceptibility of NADPHdINOS-positive neurons to glutamate agonists provides a method for selectively eliminating the NOS-containing neurons.
The regional vulnerability of the developing brain to H-I damage is different from that of the adult brain. For example, perinatal asphyxia in the term infant is more likely to damage basal ganglia and deep layers of the cortex. The transient excess of glutamate receptors in these areas in the developing brain correlates well with the injury (13) , and the selective expression of nNOS occurs temporally in regions that parallel glutamate receptor abundance (Black SM, Bedouilli M, Soifer S, Bristow J, Ferriero DM, unpublished observations). It is conceivable that the relative resistance of NOS-containing neurons to NMDA-mediated injury in the neonatal brain contributes to the greater susceptibility of the immature brain in these areas by supporting excessive production of the neurotoxic molecule NO upon stimulation with glutamate. We therefore investigated the importance of NO in the pathogenesis of H-I brain injury in the developing rat brain. We used the susceptibility of nNOS-containing neurons to low concentrations of QA to selectively eliminate these neurons before subjecting animals to a H-I insult. Our results support the hypothesis that NO generated by nNOS-containing neurons significantly contributes to H-I brain damage in this model. (14) . Animals were anesthetized with 1% halothane in NO/ oxygenlnitrogen and the right carotid artery was coagulated, followed by a 2-h period when the pups were returned to the dam to nurse and recover from the anesthetic. Then animals were placed in containers in a water bath at 37°C and exposed to 2.5 h of hypoxia (humidified 8% 0,/92% N,).
METHODS
In one litter of P7 pups, animals were subjected to topical infusion of 100 mM KC1 to the right parietal cortex to stimulate spreading depression (15, 16) . Using a blocked design, animals received either KC1 or saline 24 h before H-I.
Three weeks later, all surviving animals were killed by pentobarbital euthanasia and perfused through the left ventricle with 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4. Brains were removed and immersed in the same fixative for 4 h and transferred to 30% sucrose in 0.1 M phosphate buffer, pH 7.4. Forebrain sections were cut on a vibratome at 50-pm intervals, and alternate sections were reacted for Nissl substance, NOS immunoreactivity or NADPHd histochemistry, and microglia (0x42) and astroglia (GFAP) markers.
Briefly, the NADPHd histochemical method employs a 2-h incubation at 37°C in a solution containing 0.1 M Tris-HC1 (pH 8), 0.2 mM NADP, 15 mM sodium malate, 0.2 mM nitro blue tetrazolium, 1 mM MnC12, and 0.1% Triton X-100 (10). NOS was localized immunohistochemically with an antibody specific for nNOS (gift of Dr. S. Black, University of California, San Francisco) at 1:3000 for 24 h at 4°C. Microglia were localized with antibody to 0x42 (Serotec-MCA 275) at 1 :4000 dilution for 2 h at 23OC. Astrocytes were localized with antibody to GFAP (Peninsula) at 1:3000 dilution for 2 h at 23°C. All immunocytochemistry was performed as previously reported using the ABC method (Vector Labs, Burlingame, CA) (17) . Elimination of the primary antibody served as the control. All sections were mounted onto gelatinized slides, dehydrated, and coverslipped with Depex (Biomedical Specialties, St., Monica, CA).
Brain infarction was determined by two independent methods, by scoring brains histopathologically and by computing preserved ipsilateral hemispheric area relative to the noninvolved contralateral hemisphere. Histopathologic scoring of cresyl violet stained coronal sections was done blindly using a scale such that 0 = no injury, 1 = minimal cell loss manifested by scattered shrunken neurons and glia, 2 = moderate cell loss with infarction in a columnar distribution in the cortex with concomitant gliosis, 3 = severe cell loss and gliosis with cystic infarction. Brain area was measured in coronal slices through the forebrain at the level of the anterior commissure using a video image analysis computerized system (Macintosh; National Institutes of Health Image 1.41), and the remaining area of the ipsilateral side was expressed as percent area of the contralateral uninvolved hemisphere. NADPHd cell loss was examined from identical sterotaxic planes in each animal in the same manner as for calculation of brain area.
Statistics were performed using analysis of variance with post hoc tests for continuous data and 2 analysis for categorical data.
RESULTS
Injection of either vehicle or low dose QA into the P7 rat cortex resulted in a mild scar associated with neuronal loss restricted to the needle track and a small astroglial reaction around the injection site (Fig. 1, A and B) . There was complete loss of NADPHd-containing (nNOS) neurons throughout the parietal cortex after QA injection (Fig. ID) , but not after injection of the vehicle (Fig. 1C) . Confirmation of loss of the nNOS immunoreactive cells was evident by immunocytochemistry in the cortex with the normal distribution of these cells seen in the striatum or in the cortex of vehicle injected animals (Fig. 2) . Nissl counterstain revealed no substantial neuronal loss in the area devoid of NADPHdINOS neurons except at the superficial injection site (Fig. I) , and there was no loss of brain area in the QA-injected cortices compared with vehicle-injected brains (Table 1) .
After H-I injury, the vehicle-injected animals more often had profound injury with cystic infarction (Fig. 3 0 . Vehicleinjected animals had the same distribution of injury as animals with H-I alone without prior injection. Animals who were pretreated with intracortical QA 24 h before induction of the H-I were more likely to suffer only mild to moderate injury (Fig. 3, A and B) in the cortex, and their histopathologic injury score was significantly lower than that of animals preinjected with vehicle (Table 1 ). Brain area after infarction was likewise significantly preserved in the QA-pretreated animals compared with vehicle-treated controls (Table 1) . Animals receiving KC1 infusion 24 h before H-I to stimulate spreading depression suffered the same degree of brain injury as vehicle-infused animals.
The brains of injured animals showed a microglial reaction in the ipsilateral cortex that provided an excellent marker for the areas typically seen with this form of injury, i.e. there was a laminar distribution involving layers IS-IV with intense microglial staining in a columnar pattern in the cortex with a patchy distribution in the dorsolateral striatum (Fig. 4, C and  D) . This staining pattern correlated well with severity of injury seen histopathologically on Nissl stain and was more intense in the animals preinjected with vehicle than in the animals preinjected with QA when the injury was more severe. QA or vehicle injections alone did not cause a microglial reaction. 
Table 1. Cortical injury after H-I insult in P7 rat

DISCUSSION
stimulates NO formation in NOS neurons, but these neurons are selectively resistant to NMDA neurotoxicity. It is unclear Our results support the hypothesis that NO is a critical why the neurons that generate NO are not susceptible to its mediator of damage in the developing CNS. Local elimination of the nNOS-containing neurons by intracortical injection of destructive effects. Recent evidence suggests that, in the setting low dose QA in P7 rat cortex resulted in significant attenuation of H-I, NOS is induced in neurons by increased intracellular of the damage after H-I. There is accumulating evidence that calcium after it binds to calmodulin (3). The increased NOS NO is an important mediator of the neurotoxicity seen after activity results in large amounts of NO diffusing out of the excitatory amino acid release, especially in the setting of H-I neuron into the extracellular space where it can combine with injury, Using a mouse with targeted disruption of the gene for superoxide anion to form peroxynitrite. The generation of this n~~~, Huana et al, (7) were able to show reduced cerebral neurotoxic species results in lipid peroxidation and cytotoxicity -~, injury in the knock-out mouse. In primary cortical cultures, NOS neurons appear to be the source of neurotoxic NO, and elimination of these neurons with 20 p M QA diminish subsequent NMDA neurotoxicity (18) . These data are in agreement with our observation that selective elimination of NOScontaining neurons can prevent much of the damage caused by H-I in the developing nervous system.
The interactions between glutamate and NO in generating neurotoxicity have been elucidated by a number of recent studies. In primary cerebral cortical cell culture, glutamate neurotoxicity can be prevented by L-nitroarginine, a NOS inhibitor; and Hb, which complexes NO, prevents the neurotoxic effects of NMDA (3, 18) . NMDA receptor activation to nearby cells (6) .
This information also helps to clarify the role of NO in H-I because there have been conflicting reports regarding protection against this form of injury in different models using nonselective blockers of NOS. Some of the differences observed between models of global and focal ischemia may be due to differential activation of various NOS enzymes in endothelium, neurons, astrocytes, and microglia. When endothelial and nNOS are inhibited simultaneously in the setting of H-I, damage reduction is unpredictable and can often be worse (19) if endothelial NOS is inhibited sufficiently to prevent adequate cerebral perfusion (7) . In two focal models of H-I in the neonatal rat, NOS inhibitors reduce the injury in brain (20, PERINATAL HYPOXIA-ISCHEMIA AND NITRIC OXIDE 917 21 ). In a model of global ischemia produced by repeated episodes of umbilical cord occlusion in fetal sheep, there is preferential damage to the striatum, suggesting that the damage is due to "excitotoxic" mechanisms (22) . The use of NO inhibition in this model will yield critical information regarding the importance of NO toxicity in models of global ischemia to the developing brain.
It has previously been shown by us and others (1 1, 12 ) that the NADPHd neurons are a distinct subpopulation of neurons that have a unique profile of sensitivity to excitatory amino acids that changes during development. In vitro, these neurons become resistant to NMDA toxicity as they express NOS/ NADPH reactivity and at the same time are uniquely sensitive to low doses of the non-NMDA glutamate receptor toxin QA. The neonatal brain is remarkable in this regard because the relative sparing of the NOSNADPHd neurons is lost after the second postnatal week (11) . The relative resistance to the neurotoxic effects allows the NOS-containing neurons to continue producing NO in the setting of NMDA receptor activation associated with H-I insult. The resultant NO can then combine with other free radicals such as superoxide to form unstable intermediates such as peroxynitrite that can contribute to cell death through lipid peroxidation, enzyme deactivation, and DNA nitration (6) .
An alternative explanation for the decreased damage after intracortical QA injection in the setting of H-I may be the activation of spreading depression currents that protect the brain from further acute insults. Spreading depression is a transient phenomenon characterized by drastic depolarization of neurons and is accompanied by changes in blood flow and metabolism (23) . In the adult brain, spreading depression provoked by nonhypoxic stimuli such as mechanical, chemical or electrical stimuli, does not induce irreversible neuronal injury in an otherwise normal brain, despite glutamate release and lactate accumulation (24) . To eliminate the possibility that spreading depression provoked by QA administration protected the H-I neonatal rat brain, animals received high dose KC1 instead of QA before the H-I. There was no indication that activation of spreading depression changed the course of the injury in these animals.
A third possibility is that QA injection before the H-I insult caused a stress response with induction of heat shocklstress proteins which would protect cells from further injury. Simon et al. (25) have shown that repeated brief global H-I episodes can prevent damage to the mature rat CNS caused by subsequent focal ischemia and that these animals exhibit HSP72 production in areas of the cortex that were protected from the focal ischemic injury. It is unlikely that a single dose of QA would cause sufficient HSP induction to protect the brain from subsequent insult. In fact, in the neonatal animal, even hyperthermic insult enough to cause global HSP production does not protect the brain from future H-I (Ferriero DM, unpublished observations). In fact, we have shown HSP immunoreactivity in areas of H-I damage in this model within 24 h of H-I which did not correlate with areas later spared from neuronal loss (17) .
Finally, the effect of QA pretreatment could relate to receptor-mediated activation of the metabotropic glutamate receptor instead of its direct action on elimination of the nNOS containing cells in the cortex. In murine cortical cultures and in adult mouse brain (26, 27) activation of the metabotropic receptor with ACPD (trans-1 -aminocyclopentyl-1,3-dicarboxylic acid) attenuated cell loss due to NMDA activation or H-I. It is unlikely, however, that receptor activation continued 24 h after the single injection of QA.
In summary, we have shown that elimination of cortical NOSNADPHd containing neurons 24 h before H-I injury protects the immature rat brain from severe damage. These results support a role of glutamate-induced release of nitric oxide as a mechanism of neuronal loss seen after this form of injury. Therapies aimed at reducing NO production selectively from neurons in the neonatal brain may be of value in ameliorating the damage after H-I.
